120 related articles for article (PubMed ID: 29229318)
1. Low dose chemotherapy combined with attenuated Salmonella decreases tumor burden and is less toxic than high dose chemotherapy in an autochthonous murine model of breast cancer.
Saltzman D; Augustin L; Leonard A; Mertensotto M; Schottel J
Surgery; 2018 Mar; 163(3):509-514. PubMed ID: 29229318
[TBL] [Abstract][Full Text] [Related]
2. Attenuated Salmonella enterica Typhimurium reduces tumor burden in an autochthonous breast cancer model.
Drees J; Mertensotto M; Liu G; Panyam J; Leonard A; Augustin L; Schottel J; Saltzman D
Anticancer Res; 2015 Feb; 35(2):843-9. PubMed ID: 25667465
[TBL] [Abstract][Full Text] [Related]
3. Doxorubicin and paclitaxel enhance the antitumor efficacy of vaccines directed against HER 2/neu in a murine mammary carcinoma model.
Eralp Y; Wang X; Wang JP; Maughan MF; Polo JM; Lachman LB
Breast Cancer Res; 2004; 6(4):R275-83. PubMed ID: 15217493
[TBL] [Abstract][Full Text] [Related]
4. Improved treatment of medullary thyroid cancer in a nude mouse model by combined radioimmunochemotherapy: doxorubicin potentiates the therapeutic efficacy of radiolabeled antibodies in a radioresistant tumor type.
Behr TM; Wulst E; Radetzky S; Blumenthal RD; Dunn RM; Gratz S; Rave-Fränk M; Schmidberger H; Raue F; Becker W
Cancer Res; 1997 Dec; 57(23):5309-19. PubMed ID: 9393755
[TBL] [Abstract][Full Text] [Related]
5. Potentiation of adoptive immunotherapy by cis-diamminedichloroplatinum(II), but not by doxorubicin, on a disseminated mouse lymphoma and its association with reduction of tumor burden.
Formelli F; Rossi C; Sensi ML; Parmiani G
Int J Cancer; 1988 Dec; 42(6):952-7. PubMed ID: 3263956
[TBL] [Abstract][Full Text] [Related]
6. Virulence-attenuated
Augustin LB; Milbauer L; Hastings SE; Leonard AS; Saltzman DA; Schottel JL
J Drug Target; 2021 Apr; 29(4):430-438. PubMed ID: 33183080
[TBL] [Abstract][Full Text] [Related]
7. A phase I trial of genetically modified Salmonella typhimurium expressing cytosine deaminase (TAPET-CD, VNP20029) administered by intratumoral injection in combination with 5-fluorocytosine for patients with advanced or metastatic cancer. Protocol no: CL-017. Version: April 9, 2001.
Cunningham C; Nemunaitis J
Hum Gene Ther; 2001 Aug; 12(12):1594-6. PubMed ID: 11529249
[TBL] [Abstract][Full Text] [Related]
8. Extensive preclinical investigation of polymersomal formulation of doxorubicin versus Doxil-mimic formulation.
Alibolandi M; Abnous K; Mohammadi M; Hadizadeh F; Sadeghi F; Taghavi S; Jaafari MR; Ramezani M
J Control Release; 2017 Oct; 264():228-236. PubMed ID: 28844758
[TBL] [Abstract][Full Text] [Related]
9.
Augustin LB; Milbauer L; Hastings SE; Leonard AS; Saltzman DA; Schottel JL
J Drug Target; 2021 Mar; 29(3):294-299. PubMed ID: 32886538
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of different immunotherapy approaches toward treatment of doxorubicin-resistant and doxorubicin-sensitive transplantable rhabdomyosarcoma.
Belova OB; Vinnichuk UD; Shlakhovenko VA; Berezhnaya NM
Exp Oncol; 2007 Dec; 29(4):272-6. PubMed ID: 18199982
[TBL] [Abstract][Full Text] [Related]
11. Improved drug delivery and therapeutic efficacy of PEgylated liposomal doxorubicin by targeting anti-HER2 peptide in murine breast tumor model.
Zahmatkeshan M; Gheybi F; Rezayat SM; Jaafari MR
Eur J Pharm Sci; 2016 Apr; 86():125-35. PubMed ID: 26972276
[TBL] [Abstract][Full Text] [Related]
12. Determination of the optimal combination chemotherapy regimen for treatment of platinum-resistant ovarian cancer in nude mouse model.
Saucier JM; Yu J; Gaikwad A; Coleman RL; Wolf JK; Smith JA
J Oncol Pharm Pract; 2007 Mar; 13(1):39-45. PubMed ID: 17621566
[TBL] [Abstract][Full Text] [Related]
13. Nano-assemblies of J-aggregates based on a NIR dye as a multifunctional drug carrier for combination cancer therapy.
Song X; Zhang R; Liang C; Chen Q; Gong H; Liu Z
Biomaterials; 2015 Jul; 57():84-92. PubMed ID: 25913253
[TBL] [Abstract][Full Text] [Related]
14. Lipodox® (generic doxorubicin hydrochloride liposome injection): in vivo efficacy and bioequivalence versus Caelyx® (doxorubicin hydrochloride liposome injection) in human mammary carcinoma (MX-1) xenograft and syngeneic fibrosarcoma (WEHI 164) mouse models.
Burade V; Bhowmick S; Maiti K; Zalawadia R; Ruan H; Thennati R
BMC Cancer; 2017 Jun; 17(1):405. PubMed ID: 28587612
[TBL] [Abstract][Full Text] [Related]
15. Combining activatable nanodelivery with immunotherapy in a murine breast cancer model.
Kheirolomoom A; Silvestrini MT; Ingham ES; Mahakian LM; Tam SM; Tumbale SK; Foiret J; Hubbard NE; Borowsky AD; Ferrara KW
J Control Release; 2019 Jun; 303():42-54. PubMed ID: 30978432
[TBL] [Abstract][Full Text] [Related]
16. Doxorubicin-loaded polysaccharide nanoparticles suppress the growth of murine colorectal carcinoma and inhibit the metastasis of murine mammary carcinoma in rodent models.
Li M; Tang Z; Zhang D; Sun H; Liu H; Zhang Y; Zhang Y; Chen X
Biomaterials; 2015 May; 51():161-172. PubMed ID: 25771007
[TBL] [Abstract][Full Text] [Related]
17. Combined radiofrequency ablation and adjuvant liposomal chemotherapy: effect of chemotherapeutic agent, nanoparticle size, and circulation time.
Ahmed M; Lukyanov AN; Torchilin V; Tournier H; Schneider AN; Goldberg SN
J Vasc Interv Radiol; 2005 Oct; 16(10):1365-71. PubMed ID: 16221908
[TBL] [Abstract][Full Text] [Related]
18. Treatment of metastatic breast cancer by combination of chemotherapy and photothermal ablation using doxorubicin-loaded DNA wrapped gold nanorods.
Wang D; Xu Z; Yu H; Chen X; Feng B; Cui Z; Lin B; Yin Q; Zhang Z; Chen C; Wang J; Zhang W; Li Y
Biomaterials; 2014 Sep; 35(29):8374-84. PubMed ID: 24996756
[TBL] [Abstract][Full Text] [Related]
19. Pegylated Liposomal Doxorubicin as Adjuvant Therapy for Stage I-III Operable Breast Cancer.
Lu YC; Ou-Yang FU; Hsieh CM; Chang KJ; Chen DR; Tu CW; Wang HC; Hou MF
In Vivo; 2016; 30(2):159-63. PubMed ID: 26912829
[TBL] [Abstract][Full Text] [Related]
20. Combined therapeutic effect of a monoclonal anti-idiotype tumor vaccine against NeuGc-containing gangliosides with chemotherapy in a breast carcinoma model.
Fuentes D; Avellanet J; Garcia A; Iglesias N; Gabri MR; Alonso DF; Vazquez AM; Perez R; Montero E
Breast Cancer Res Treat; 2010 Apr; 120(2):379-89. PubMed ID: 19377876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
